Indegene Limited (BOM:544172)

India flag India · Delayed Price · Currency is INR
478.90
+1.55 (0.32%)
At close: Jan 20, 2026
-27.36%
Market Cap113.84B
Revenue (ttm)30.41B
Net Income (ttm)4.46B
Shares Outn/a
EPS (ttm)18.50
PE Ratio25.54
Forward PE23.05
Dividend2.00 (0.42%)
Ex-Dividend DateJun 13, 2025
Volume7,828
Average Volume8,672
Open477.40
Previous Close477.35
Day's Range471.45 - 482.95
52-Week Range471.45 - 681.10
Betan/a
RSI22.86
Earnings DateJan 29, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo... [Read more]

Industry Commercial Physical and Biological Research
Founded 1998
Employees 4,158
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544172
Full Company Profile

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.

Financial Statements